Status:
COMPLETED
Lipid Efficacy Study (0524B-022)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Primary Hypercholesterolemia
Mixed Hyperlipidemia
Eligibility:
All Genders
18-85 years
Phase:
PHASE3
Brief Summary
This is a 12-week clinical trial in patients with primary hypercholesterolemia or mixed hyperlipidemia, studying the effects of coadministered MK0524B on lipids. There will be 6 scheduled clinic visit...
Eligibility Criteria
Inclusion
- Patients 18 to 85 years of age with primary hypercholesterolemia or mixed hyperlipidemia
- LDL-C between 130 and 190 mg/L (Category I) and 130 and 160 mg/L (Category II) and triglycerides \</= 350 mg/dL.
Exclusion
- A condition which, in the opinion of the investigator, might pose a risk to the patient or interfere with participating in the study
- Patients with \<80% compliance
- Patients with certain medical conditions
- Patients taking certain concomitant medications and/or with unstable doses of medications
- Or those with a history of CHD/CHD equivalent or diabetes
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
1400 Patients enrolled
Trial Details
Trial ID
NCT00269217
Start Date
January 1 2006
End Date
January 1 2007
Last Update
April 7 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.